We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B Turnover 25.53%
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+29.97%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.46B
AUM Growth
+$496M
Cap. Flow
+$126M
Cap. Flow %
5.12%
Top 10 Hldgs %
38.02%
Holding
188
New
26
Increased
91
Reduced
27
Closed
22
Avg Time Held
2.6 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
2.4 years

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$52.1M
2
DXCM icon
DexCom
DXCM
+$46.7M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.53M
4
PH icon
Parker-Hannifin
PH
+$5.29M
5
AVGO icon
Broadcom
AVGO
+$5.08M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$24.9M
2
KLAC icon
KLA
KLAC
+$21.4M
3
WDAY icon
Workday
WDAY
+$21M
4
FIX icon
Comfort Systems
FIX
+$14.1M
5
TSM icon
TSMC
TSM
+$8.27M

Sector Composition

Rank Sector Weight
1 Technology 39.09%
2 Financials 11.79%
3 Communication Services 11.58%
4 Industrials 11.01%
5 Healthcare 10.91%

No holdings matched the selected filter criteria.

Similar funds

Smith Group Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Smith Group Asset Management held 188 positions worth $2.46B, up 25% from $1.96B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Smith Group Asset Management deployed $126M of net new capital in Q2 2026, opening 26 new positions and adding to 91 existing holdings. Its largest new stake was DexCom: 701,347 shares worth $47.2M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 32% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was KLA, an estimated $21.4M trimmed.

  • Smith Group Asset Management's largest Q2 2026 buy was DexCom: 701,347 shares worth $47.2M.
  • Smith Group Asset Management added most to Lam Research in Q2 2026, an estimated $52.1M increase.
  • Smith Group Asset Management's biggest Q2 2026 reduction was KLA, cutting an estimated $21.4M.
  • Smith Group Asset Management fully exited Vertex Pharmaceuticals in Q2 2026, selling an estimated $24.9M.
  • Smith Group Asset Management's ten largest holdings make up 38% of its $2.46B portfolio in Q2 2026.
  • Smith Group Asset Management opened 26 new positions and closed 22 in Q2 2026.
  • Smith Group Asset Management's portfolio value rose 25% quarter-over-quarter to $2.46B.

Based on Smith Group Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.